Rgene (Enzymes) Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $491K

  • Investors
  • 1

Rgene (Enzymes) General Information

Description

Developer of enzymes designed to use in molecular biology and genomics research. The company's products use protein engineering to improve enzyme properties for better in vitro application enabling enzyme reagents using protein engineering and data mining methods for molecular biotechnology.

Contact Information

Website
www.rgeneresearch.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (617) 000-0000
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rgene (Enzymes) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 27-Mar-2015 $491K Completed Startup
To view Rgene (Enzymes)’s complete valuation and funding history, request access »

Rgene (Enzymes) Patents

  • 18

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 14

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Rgene (Enzymes) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190062827-A1 Hyper-thermostable lysine-mutant ssdna/rna ligases Inactive 14-Mar-2016 0000000000
EP-3430154-B1 Hyper-thermostable lysine-mutant ssdna/rna ligases Active 14-Mar-2016 000000000 0
EP-3430154-A4 Hyper-thermostable lysine-mutant ssdna/rna ligases Active 14-Mar-2016 0000000000 0
EP-3430154-A2 Hyper-thermostable lysine-mutant ssdna/rna ligases Active 14-Mar-2016 0000000000
AU-2017218431-B2 Multiple ligase compositions, systems, and methods Active 08-Feb-2016 C12N9/93
To view Rgene (Enzymes)’s complete patent history, request access »

Rgene (Enzymes) Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of General Medical Sciences Government 000 0000 000000 0
To view Rgene (Enzymes)’s complete investors history, request access »

Ready to get started?

Request a free trial

Rgene (Enzymes) FAQs

  • When was Rgene (Enzymes) founded?

    Rgene (Enzymes) was founded in 2014.

  • Who is the founder of Rgene (Enzymes)?

    Yu Zheng Ph.D is the founder of Rgene (Enzymes).

  • Where is Rgene (Enzymes) headquartered?

    Rgene (Enzymes) is headquartered in San Francisco, CA.

  • What industry is Rgene (Enzymes) in?

    Rgene (Enzymes)’s primary industry is Biotechnology.

  • Is Rgene (Enzymes) a private or public company?

    Rgene (Enzymes) is a Private company.

  • What is Rgene (Enzymes)’s current revenue?

    The current revenue for Rgene (Enzymes) is 000000.

  • Who are Rgene (Enzymes)’s investors?

    National Institute of General Medical Sciences has invested in Rgene (Enzymes).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »